Hyperfractionated radiotherapy and simultaneous cisplatin for stage-III and-IV carcinomas of the head and neck

1 August 1998

journal article
other
Published by Springer Nature in Strahlentherapie und Onkologie

Vol. 174 (8) , 397-402
https://doi.org/10.1007/bf03038560

Abstract

To assess the survival rate, the probability of local control, the patterns of relapse and late sequelae including self-reported quality of life in patients treated with hyperfractionated radiotherapy (RT) and simultaneous CDDP chemotherapy for stage-III to stage-IV carcinomas of the head and neck.

Keywords

This publication has 15 references indexed in Scilit:

Five-Year Update of a Randomized Trial of Alternating Radiotherapy and Chemotherapy Compared With Radiotherapy Alone in Treatment of Unresectable Squamous Cell Carcinoma of the Head and Neck
JNCI Journal of the National Cancer Institute, 1996
Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study
Oral Oncology, 1995
Development of a European Organization for Research and Treatment of Cancer (Eortc) Questionnaire Module to be Used in Quality of Life Assessments in Head and Neck Cancer Patients
Acta Oncologica, 1994
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
JNCI Journal of the National Cancer Institute, 1993
Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
Radiotherapy and Oncology, 1992
Treatment of Advanced Squamous-Cell Carcinoma of the Head and Neck with Alternating Chemotherapy and Radiotherapy
New England Journal of Medicine, 1992
Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer
International Journal of Radiation Oncology*Biology*Physics, 1991
Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma
International Journal of Radiation Oncology*Biology*Physics, 1991
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
New England Journal of Medicine, 1990
Adjuvant chemotherapy in head and neck cancer
British Journal of Cancer, 1990